收藏本站
我的資料
我的訂單
  購物車 (0)  
親,您的購物車空空的喲~
去購物車結(jié)算
   
查看手機網(wǎng)站
其他賬號登錄: 注冊 登錄
150-21460884
產(chǎn)品分類
SCR130 
SCR130
收藏
|
|
英文名稱 : SCR130
貨號 : EY-01Y10474
CAS : 2377858-38-1
含量 : >98.00%
規(guī)格 : 5 mg、10 mg
品牌 : 上海一研
價格 :
0.00
購買數(shù)量:
加入購物車  立即購買
產(chǎn)品保證
正品保證
快速發(fā)貨
產(chǎn)品詳情
產(chǎn)品評論(0)
銷售記錄(0)

產(chǎn)品屬性:


產(chǎn)品名稱

SCR130

規(guī)格

5 mg、10 mg

貨號

EY-01Y10474

Cas No.: 2377858-38-1

別名: N/A

化學(xué)名: N/A

分子式: C19H13Cl2N3O2S
GC62693.png
分子量: 418.3

溶解度: N/A

儲存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping ConditionEvaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述:


SCR130 is a SCR7-based DNA nonhomologous end-joining (NHEJ) inhibitor. SCR130 inhibits the end-joining of DNA in a Ligase IV-dependent manner. SCR130 is specific to Ligase IV, and shows minimal or no effect on Ligase III and Ligase I mediated joining. SCR130 induces cell apoptosis and has anticancer activity[1].SCR130 (7-21 μM; 48 hours) increase in the number of late and early apoptotic cells. SCR130 induces apoptosis by both intrinsic and extrinsic pathways. SCR130 increases the expression of p-p53, BCL2 and MCL1, and CYTOCHROME C, BAX, and BAK also increaseed. The activation of caspase 8, increase in expression of FAS and SMAC-DIABLO proteins are also observed[1].SCR130 (48 hours) exhibits cytotoxicity in Reh, HeLa, CEM, Nalm6, and N114 cells with IC50 values of 14.1 μM, 5.9 μM, 6.5 μM, 2.2 μM, and 11 μM, respectively[1].SCR130 can potentiate the effect of radiation (0.5 and 1 Gy) by inducing enhanced cell death upon coadministration in Reh and Nalm6 cell lines[1].SCR130 blocks the endogenous NHEJ leading to accumulation of unrepaired DNA breaks. Treatment with SCR130 leads to inhibition of endogenous NHEJ, resulting in the accumulation of DNA double-strand breaks (DSBs) and cell death by activating apoptotic pathways[1].[1]. Ujjayinee Ray, et al. Identification and characterization of novel SCR7-based small-molecule inhibitor of DNA end-joining, SCR130 and its relevance in cancer therapeutics. Mol Carcinog. 2020 Jun;59(6):618-628.
特別提醒公司產(chǎn)品僅供科研使用


買家數(shù)量成交時間
正品保障

確保所有產(chǎn)品都是原裝正品

優(yōu)質(zhì)服務(wù)

優(yōu)質(zhì)服務(wù),售后無憂

安全包裝

統(tǒng)一包裝,保障產(chǎn)品安全運輸

正規(guī)發(fā)票

機打發(fā)票,附箱送達

    配送方式            新手入門           售后服務(wù)           幫助中心           支付方式           關(guān)于我們
      包裝說明                會員服務(wù)                退款說明                服務(wù)協(xié)議               預(yù)付賬戶               聯(lián)系一研
      商品驗收                積分規(guī)則               退換款地址            投訴建議                發(fā)票制度
      配送查詢                購物流程                退換款流程            聯(lián)系客服               付款周期
      配送說明                會員體系                退換款原則            找回密碼               付款方式
手機掃一掃
訪問手機網(wǎng)站